Telephone: +1 317 459 4596
E-mail: info@globalclinicalpartners.com
E-mail: info@globalclinicalpartners.com
Global Clinical Partners, Inc. "GCP - not just who we are, but what we do."
Educational programs, seminars/webinars and pdf slide sets available upon request. Topics include, but are not limited to:| 1. | Responsibility: the Key to uncompromised Data
PI Responsibility as ICH prescribes PI Responsibility as FDA prescribes The Certified Physician Investigator (CPI) |
| 2. | Human Subject Safety
Ethics in Clinical Research - Protecting Human Subjects - An overview |
| 3. | Informed Consent - the Process - what it is and how it is essential |
| 4. | Oversight in Clinical Research - How Important - IRB, REB, IEC by any name
The IRB and Human Subject Protection |
| 5. | Clinical Trail management - putting it all together
Understanding 21 CFR Part 11 - Overview of Computer use in Clinical Research Protocol Deviations / Violations - Why this is important to know |
| 6. | Recruiting Study Participants - What are the steps |
| 7. | Health Insurance Portability and Accountability Act of 1996: HIPAA overview |
| 8. | FDA Audit / Inspection - What to expect and how its done
FDAs Role in Drug / Device development |
| 9. | Regulatory Control of Drug Development - How and why
Comparing ICH with the FDA CFR |
| 10. | Importance of SOPs - What are they - how are they set-up |
| 11. | Adverse Event Reporting in Clinical Research - Importance and the algorithm needed
Adverse Device Effects / UADE - Importance MedDRA Overview Risk Management in Clinical Research |
| 12. | Laboratory Data as AE's - Understanding Lab data as AE's
Good Laboratory Practices (GLP) Overview |
| 13. | Drug-induced Hepatotoxicity - How to identify it & what is its role in drug safety |
| 14. | Pharmacovigilance (Post Marketing drug Safety) - why it is important |
| 15. | Data and Safety Monitoring - How Important are DSMP's and DSMB's |
| 16. | Confined Studies: Phase I and IIa - What are they and how are they set up |
| 17. | Phase I - "First-in-Man" - What is special about early trials with a new drug |
| 18. | PK / Metabolism / Interactions for Investigators - Basic overview |
| 19. | GCP, an Investigators update - the elements of GCP |
| 20. | Documentation in Clinical Research - Importance and how to do it |
| 21. | Conflict of Interest Guidelines (CoI) - the importance of having a system |






